Minoza, Shemie P.
HRN: 24-51-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/25/2024
MUPIROCIN 2%, 15G (TUBE)
01/25/2024
01/31/2024
TOPICAL
15g
OD X 7 Days
S/P Primary LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes